HBAN vs JAZZ · P/E 13, rev $1.56B vs P/E 1988, rev $2.28B
Huntington Bancshares Incorporated (HBAN) versus Jazz Pharmaceuticals PLC (JAZZ) — a side-by-side from cached financials, not a winner call.
Huntington Bancshares Incorporated (HBAN) is a banks - regional company listed on US.
Jazz Pharmaceuticals PLC (JAZZ) is a biotechnology company listed on US.
Latest reported HBAN revenue for 2025-12-31 was $1.56B. Net income was $2.21B. Revenue was up 6.4% from 2024-12-31 to 2025-12-31. HBAN currently screens at market cap $25.55B and trailing P/E 13.5.
Latest reported JAZZ revenue for 2026-06-30 was $2.28B. Net income was $485.9M. JAZZ currently screens at market cap $14.97B and trailing P/E 1988.1.
HBAN currently screens at market cap $25.55B and trailing P/E 13.5. JAZZ currently screens at market cap $14.97B and trailing P/E 1988.1.
Not investment advice. Open the HBAN and JAZZ stock pages for the full models.
Not investment advice.